The exacerbation observed for SERPINA3 mRNA in iCJD samples may be explained by the younger age of these patients (29 years on average) if compared to the other acquired from of CJD studied (vCJD, 35 years on average) who might display a stronger reactivity to the infection. The gene discussed is SERPINA3; the disease is variant Creutzfeldt-Jakob disease.